SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-275176
Filing Date
2021-09-16
Accepted
2021-09-16 16:34:00
Documents
16
Period of Report
2021-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d223807d8k.htm   iXBRL 8-K 32179
2 EX-4.1 d223807dex41.htm EX-4.1 126612
3 EX-10.1 d223807dex101.htm EX-10.1 247955
4 EX-99.1 d223807dex991.htm EX-99.1 9641
8 GRAPHIC g223807g72e85.jpg GRAPHIC 1853
  Complete submission text file 0001193125-21-275176.txt   629558

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vinc-20210915.xsd EX-101.SCH 2916
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20210915_lab.xml EX-101.LAB 18888
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20210915_pre.xml EX-101.PRE 11876
9 EXTRACTED XBRL INSTANCE DOCUMENT d223807d8k_htm.xml XML 3474
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 211258336
SIC: 2834 Pharmaceutical Preparations